Lymphedema in Gynecologic Oncology
Özet
Lymphedema is a chronic disorder characterized by the accumulation of protein-rich fluid in the tissues due to impaired lymphatic drainage, resulting in inflammation and tissue damage. In gynecologic oncology, lower extremity lymphedema (LEL) represents a significant morbidity, particularly following pelvic and para-aortic lymph node dissection and adjuvant radiotherapy. The reported incidence of LEL ranges from 1.2% to 39%, varying with surgical technique, radiotherapy protocols, body mass index, age, and comorbidities. Diagnosis is primarily based on clinical evaluation and circumferential limb measurements, supported by imaging modalities such as lymphoscintigraphy and magnetic resonance imaging. The risk of lymphedema differs among gynecologic cancers, being highest in vulvar cancer and lowest in ovarian cancer. In cervical and endometrial cancers, the extent of lymph node dissection significantly influences risk. Management requires a multidisciplinary approach focusing on patient education, infection prevention, and preservation of mobility. The current gold-standard treatment is Complex Decongestive Therapy (CDT), which includes manual lymph drainage, compression, skin care, and exercise. In refractory cases, surgical interventions such as liposuction may be considered. Sentinel lymph node mapping and lymph node–sparing surgical techniques offer promising strategies for reducing lymphedema risk.
Referanslar
Foldi M, Foldi E, editors. Foldi's textbook of lymphology for physicians and lymphedema therapists. Mosby; 2006.
Damstra RJ. Diagnostic and therapeutical aspects of lymphedema.
Ridner SH. Pathophysiology of lymphedema. InSeminars in oncology nursing 2013 Feb 1 (Vol. 29, No. 1, pp. 4-11). WB Saunders.
Michael JA, Sircar S. Fundamentals of medical physiology. (No Title). 2010.
Rockson SG. Update on the biology and treatment of lymphedema. Current treatment options in cardiovascular medicine. 2012 Apr;14(2):184-92.
Olszewski WL, Engeset AR. Intrinsic contractility of prenodal lymph vessels and lymph flow in human leg. American Journal of Physiology-Heart and Circulatory Physiology. 1980 Dec 1;239(6):H775-83.
Grada AA, Phillips TJ. Lymphedema: Pathophysiology and clinical manifestations. Journal of the American Academy of Dermatology. 2017 Dec 1;77(6):1009-20.
Mallon EC, Ryan TJ. Lymphedema and wound healing. Clinics in dermatology. 1994 Jan 1;12(1):89-93.
Mortimer PS, Rockson SG. New developments in clinical aspects of lymphatic disease. The Journal of clinical investigation. 2014 Mar 3;124(3):915-21.
Brennan MJ, Miller LT. Overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema. Cancer: Interdisciplinary International Journal of the American Cancer Society. 1998 Dec 15;83(S12B):2821-7.
Abu-Rustum NR, Alektiar K, Iasonos A, Lev G, Sonoda Y, Aghajanian C, Chi DS, Barakat RR. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecologic oncology. 2006 Nov 1;103(2):714-8.: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol.2006;103:714Y718.
Bergmark K, Åvall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls. International Journal of Gynecological Cancer. 2006 Apr 1;16(3):1130-9.
Tanaka T, Ohki N, Kojima A, Maeno Y, Miyahara Y, Sudo T, Takekida S, Yamaguchi S, Sasaki H, Nishimura R. Radiotherapy negates the effect of retroperitoneal nonclosure for prevention of lymphedema of the legs following pelvic lymphadenectomy for gynecological malignancies: an analysis from a questionnaire survey. International Journal of Gynecological Cancer. 2007 Feb 1;17(2):460-4.
Tada H, Teramukai S, Fukushima M, Sasaki H. Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma. BMC cancer. 2009 Feb 5;9(1):47.BMC Cancer. 2009;9:47.
Kim JH, Choi JH, Ki EY, Lee SJ, Yoon JH, Lee KH, Park TC, Park JS, Bae SN, Hur SY. Incidence and risk factors of lower-extremity lymphedema after radical surgery with or without adjuvant radiotherapy in patients with FIGO stage I to stage IIA cervical cancer. International Journal of Gynecological Cancer. 2012 May 1;22(4):686-91.
Todo Y, Yamamoto R, Minobe S, Suzuki Y, Takeshi U, Nakatani M, Aoyagi Y, Ohba Y, Okamoto K, Kato H. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecologic oncology. 2010 Oct 1;119(1):60-4.
Beesley V, Janda M, Eakin E, Obermair A, Battistutta D. Lymphedema after gynecological cancer treatment: prevalence, correlates, and supportive care needs. Cancer. 2007 Jun 15;109(12):2607-14.
ISL I. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology. 2013 Aug 19;46(1):1-1.
Brown J. A clinically useful method for evaluating lymphedema. Clinical journal of oncology nursing. 2004 Feb 1;8(1).
Lockwood-Rayermann S. Lymphedema in gynecologic cancer survivors: an area for exploration?. Cancer nursing. 2007 Jul 1;30(4):E11-8.
Suehiro K, Morikage N, Murakami M, Yamashita O, Samura M, Hamano K. Significance of ultrasound examination of skin and subcutaneous tissue in secondary lower extremity lymphedema. Annals of vascular diseases. 2013 Jun 25;6(2):180-8.
Hoffner M, Peterson P, Månsson S, Brorson H. Lymphedema leads to fat deposition in muscle and decreased muscle/water volume after liposuction: a magnetic resonance imaging study. Lymphatic research and biology. 2018 Apr 1;16(2):174-81.
Mazzei FG, Gentili F, Guerrini S, Cioffi Squitieri N, Guerrieri D, Gennaro P, Scialpi M, Volterrani L, Mazzei MA. MR lymphangiography: a practical guide to perform it and a brief review of the literature from a technical point of view. BioMed research international. 2017;2017(1):2598358.
Yamada K, Shinaoka A, Kimata Y. Three-dimensional imaging of lymphatic system in lymphedema legs using interstitial computed tomography-lymphography. Acta Med Okayama. 2017 Apr 1;71(2):171-7.
Moshiri M, Katz DS, Boris M, Yung E. Using lymphoscintigraphy to evaluate suspected lymphedema of the extremities. American Journal of Roentgenology. 2002 Feb;178(2):405-12.
Yamamoto T, Matsuda N, Doi K, Oshima A, Yoshimatsu H, Todokoro T, Ogata F, Mihara M, Narushima M, Iida T, Koshima I. The earliest finding of indocyanine green lymphography in asymptomatic limbs of lower extremity lymphedema patients secondary to cancer treatment: the modified dermal backflow stage and concept of subclinical lymphedema. Plastic and Reconstructive surgery. 2011 Oct 1;128(4):314e-21e.
Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global cancer in women: burden and trends. Cancer epidemiology, biomarkers & prevention. 2017 Apr 1;26(4):444-57.
Snijders-Keilholz A, Hellebrekers BW, Zwinderman AH, Van De Vijver MJ, Trimbos JB. Adjuvant radiotherapy following radical hysterectomy for patients with early-stage cervical carcinoma (1984-1996). Radiotherapy and oncology. 1999 May 1;51(2):161-7.
Werngren-elgström M, Lidman D. Lymphoedema of the lower extremities after surgery and radiotherapy for cancer of the cervix. Scandinavian journal of plastic and reconstructive surgery and hand surgery. 1994 Jan 1;28(4):289-93.
Frøding LP, Ottosen C, Mosgaard BJ, Jensen PT. Quality of life, urogynecological morbidity, and lymphedema after radical vaginal trachelectomy for early-stage cervical cancer. International Journal of Gynecological Cancer. 2015 May 1;25(4):699-706.
Biglia N, Librino A, Ottino MC, Panuccio E, Daniele A, Chahin A. Lower limb lymphedema and neurological complications after lymphadenectomy for gynecological cancer. International Journal of Gynecological Cancer. 2015 Mar 1;25(3):521-5.
Lim MC, Lee JS, Nam BH, Seo SS, Kang S, Park SY. Lower extremity edema in patients with early ovarian cancer. Journal of Ovarian Research. 2014 Mar 7;7(1):28.
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): head and neck cancers. Fort. Washington, PA: National Comprehensive Cancer Network. 2019.
SALEHI S, STÅLBERG K, MARCICKIEWICZ J, ROSENBERG P, FALCONER H. Allt bättre diagnostik och behandling vid endometriecancer. LAKARTIDNINGEN. 2015;112(50):2284.
Ryan M, Stainton MC, Slaytor EK, Jaconelli C, Watts S, MacKenzie P. Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. Australian and New Zealand journal of obstetrics and gynaecology. 2003 Apr;43(2):148-51.
Farrell R, Gebski V, Hacker NF. Quality of life after complete lymphadenectomy for vulvar cancer: do women prefer sentinel lymph node biopsy?. International Journal of Gynecological Cancer. 2014 May 1;24(4):813-9.
Moore RG, Robison K, Brown AK, DiSilvestro P, Steinhoff M, Noto R, Brard L, Granai CO. Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial. Gynecologic oncology. 2008 Apr 1;109(1):65-70.
Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM. Lymphedema beyond breast cancer: A systematic review and meta‐analysis of cancer‐related secondary lymphedema. Cancer. 2010 Nov 15;116(22):5138-49.
Tiwari P, Coriddi M, Salani R, Povoski SP. Breast and gynecologic cancer-related extremity lymphedema: a review of diagnostic modalities and management options. World journal of surgical oncology. 2013 Sep 22;11(1):237.
Morgan PA, Franks PJ, Moffatt CJ. Health‐related quality of life with lymphoedema: a review of the literature. International wound journal. 2005 Mar;2(1):47-62.
Földi E, Földi M, Weissleder H. Conservative treatment of lymphoedema of the limbs. Angiology. 1985 Mar;36(3):171-80.
Franks PJ, Moffatt CJ, Doherty DC, Williams AF, Jeffs E, Mortimer PS. Assessment of health‐related quality of life in patients with lymphedema of the lower limb. Wound Repair and Regeneration. 2006 Mar;14(2):110-8.
Lasinski BB. Complete decongestive therapy for treatment of lymphedema. InSeminars in oncology nursing 2013 Feb 1 (Vol. 29, No. 1, pp. 20-27). WB Saunders.
Gloviczki P, Calcagno D, Schirger A, Pairolero PC, Cherry KJ, Hallett JW, Wahner HW. Noninvasive evaluation of the swollen extremity: experiences with 190 lymphoscintigraphic examinations. Journal of vascular surgery. 1989 May 1;9(5):683-90.
Chang CJ, Cormier JN. Lymphedema interventions: exercise, surgery, and compression devices. InSeminars in oncology nursing 2013 Feb 1 (Vol. 29, No. 1, pp. 28-40). WB Saunders.
Biglia N, Zanfagnin V, Daniele A, Robba E, Bounous VE. Lower body lymphedema in patients with gynecologic cancer. Anticancer Research. 2017 Aug 1;37(8):4005-15.
Hareyama H, Ito K, Hada K, Uchida A, Hayakashi Y, Hirayama E, Oikawa M, Okuyama K. Reduction/prevention of lower extremity lymphedema after pelvic and para-aortic lymphadenectomy for patients with gynecologic malignancies. Annals of surgical oncology. 2012 Jan;19(1):268-73.
National Cancer Control Programme. Prevention of Clinical Lymphoedema after Cancer
Treatment: Early Detection and Risk Reduction. A guide for Health Professionals. Available
online: https://www.hse.ie/eng/services/list/5/cancer/patient/leaflets/prevention-of-clinical-lymphoedema-after-cancer-treatment.pdf (accessed on 06 August 2025).
Cheifetz O, Haley L. Management of secondary lymphedema related to breast cancer. Canadian Family Physician. 2010 Dec 1;56(12):1277-84.
